Timothy M. Uyeki

Timothy M. Uyeki

Auto-generated profile, based on publicly available information

Timothy M. Uyeki

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
ECEric J. Chow
Eric J. Chow
TUTimothy M. Uyeki
Timothy M. Uyeki
HCHelen Y. Chu
Helen Y. Chu

26 August 2022 in The Lancet
Verified
Journal Article
Closed access
TUTimothy M Uyeki
Timothy M Uyeki
DHDavid S Hui
David S Hui
MZMaria Zambon
Maria Zambon
DWDavid E Wentworth
David E Wentworth
AMArnold S Monto
Arnold S Monto

19 December 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TUTimothy M Uyeki
Timothy M Uyeki
HBHenry H Bernstein
Henry H Bernstein
JBJohn S Bradley
John S Bradley
JEJanet A Englund
Janet A Englund
TFThomas M File
Thomas M File
APAndrew T Pavia
Andrew T Pavia
These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. It is intended for use by primary care clinicians, obstetricians, emergency medicine providers, hospitalists, laboratorians, and infectious disease specialists, as well as other clinicians managing patients with suspected or laboratory-confirmed influenza. The guidelines consider the care of children and adults, including special populations such as pregnant and postpartum women and immunocompromised patients.

6 August 2010
Verified
Journal Article
Closed access
AFAnthony E Fiore
Anthony E Fiore
TUTimothy M Uyeki
Timothy M Uyeki
KBKaren Broder
Karen Broder
LFLyn Finelli
Lyn Finelli
GEGary L Euler
Gary L Euler
NCNancy J Cox
Nancy J Cox

5 March 2019 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TUTimothy M Uyeki
Timothy M Uyeki
HBHenry H Bernstein
Henry H Bernstein
JBJohn S Bradley
John S Bradley
JEJanet A Englund
Janet A Englund
TFThomas M File
Thomas M File
APAndrew T Pavia
Andrew T Pavia
Seasonal influenza A and B virus epidemics are associated with significant morbidity and mortality each year in the United States and worldwide. One study estimated that during 2010–2016, the seasonal incidence of symptomatic influenza among all ages in the United States was approximately 8% and varied from 3% to 11% [1]. Most people recover from uncomplicated influenza, but influenza can cause complications that result in severe illness and death, particularly among very young children, older adults, pregnant and postpartum women within 2 weeks of delivery, people with neurologic disorders, and people with certain chronic medical conditions including chronic pulmonary, cardiac, and metabolic disease, and those who are immunocompromised [2–8]. During 2010–2018, seasonal influenza epidemics were associated with an estimated 4.3–23 million medical visits, 140 000–960 000 hospitalizations, and 12 000–79 000 respiratory and circulatory deaths each year in the United States [9]. A recent modeling study estimated that 291 243–645 832 seasonal influenza–associated respiratory deaths occur annually worldwide [10].

6 June 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
TUTimothy M. Uyeki
Timothy M. Uyeki
SMScott Milton
Scott Milton
CHCherissa Abdul Hamid
Cherissa Abdul Hamid
CWCynthia Reinoso Webb
Cynthia Reinoso Webb
SPSteven M. Presley
Steven M. Presley
CDC. Todd Davis
C. Todd Davis